Gene · 5047
Papers3,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proof-of-Concept for Long-Term Human Endometrial Epithelial Organoids in Modeling Menstrual Cycle Responses. | Cells | 2024 | 39513919 | PubTator, text mining | PubMed |
| Multiomics Analysis Identifies Prognostic Signatures for Sepsis-Associated Hepatocellular Carcinoma in Emergency Medicine. | Emerg Med Int | 2024 | 39421149 | PubTator, text mining | PubMed |
| Polyethylene Glycol-Enzyme Nanocomplexes as Carrier-free Biocatalyst for Pickering Interfacial Catalysis. | ACS Appl Bio Mater | 2024 | 39365689 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Angiogenesis and Ferroptosis Genes for Predicting the Survival Outcome and Immunotherapy Response of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2024 | 39364435 | PubTator, text mining | PubMed |
| Acyl-CoA long-chain synthetase 1 (ACSL1) protects the endometrium from excess palmitic acid stress during decidualization. | Cell Signal | 2024 | 39343116 | PubTator, text mining | PubMed |
| Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles. | Mol Pharm | 2024 | 39324825 | PubTator, text mining | PubMed |
| Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis. | J Clin Med | 2024 | 39274229 | PubTator, text mining | PubMed |
| Comparison of distance versus in-person laparoscopy training using a low-cost laparoscopy simulator-a randomized controlled multi-center trial. | Surg Endosc | 2024 | 39269479 | PubTator, text mining | PubMed |
| Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis. | Amyloid | 2024 | 39126640 | PubTator, text mining | PubMed |
| Deciphering the interaction between PKM2 and the built-in thermodynamic properties of the glycolytic pathway in cancer cells. | J Biol Chem | 2024 | 39121998 | PubTator, text mining | PubMed |
| Site-specific N-glycoproteomic analysis reveals up-regulated fucosylation in seminal plasma of asthenozoospermia. | Glycobiology | 2024 | 39073901 | PubTator, text mining | PubMed |
| A 3.2 kW Single Stage Narrow Linewidth Fiber Amplifier Emitting at 1050 nm. | Micromachines (Basel) | 2024 | 39064383 | PubTator, text mining | PubMed |
| The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer. | Int J Mol Sci | 2024 | 39063239 | PubTator, text mining | PubMed |
| FOCUS on NOD2: Advancing IBD Drug Discovery with a User-Informed Machine Learning Framework. | ACS Med Chem Lett | 2024 | 39015268 | PubTator, text mining | PubMed |
| Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles. | Biomacromolecules | 2024 | 38918933 | PubTator, text mining | PubMed |
| Multi-omic profiling of breast tumor microenvironment uncovers a role of mitochondrial calcium gatekeepers. | J Cancer | 2024 | 38911376 | PubTator, text mining | PubMed |
| Microgels for Cell Delivery in Tissue Engineering and Regenerative Medicine. | Nanomicro Lett | 2024 | 38884868 | PubTator, text mining | PubMed |
| Investigation of the Rapid Emergence of Colistin Resistance in a Newborn Infected with KPC-2-Producing Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae. | J Glob Antimicrob Resist | 2024 | 38849114 | PubTator, text mining | PubMed |
| NK-92 cells labeled with Fe3O4-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer. | J Nanobiotechnology | 2024 | 38840120 | PubTator, text mining | PubMed |
| Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin. | Mol Pharm | 2024 | 38743264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5047/papers?page=7